Wholesale of pharmaceutical and medical goods
TMOS PHARMA AS
Revenue 2024
NOK 1.4m
Operating profit
NOK −308,000
Equity
NOK −114,000
Incorporated
2018
Share capital
NOK 43,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.4m | |
| Total operating costs | 1.7m | |
| Operating profit (EBIT) | −308k | |
| Net financial items | −125k | |
| Profit for the year | −433k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1.2m | |
| of which current assets | 1.2m | |
| Equity | −114k | |
| Total liabilities | 1.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.